Frovocimab (Anti-PCSK9)

Frovocimab (Anti-PCSK9) is a humanized IgG4 monoclonal antibody that neutralizes proprotein convertase subtilisin-kexin type 9 (PCSK9). MW: 146.88 KD.
Supplier Selleck Chemicals
Product # A2876
Sku # A2876-1mg*25
Pricing 1mg*25, $5070.00
Feedback